Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 27, 2025 Off

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

By GlobeNewswire

SAN DIEGO, June 26, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary…

June 27, 2025 Off

Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting Results

By GlobeNewswire

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, June 26, 2025 (GLOBE…

June 27, 2025 Off

Teva Releases Q2 2025 Aide Memoire

By GlobeNewswire

TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that…

June 27, 2025 Off

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

By GlobeNewswire

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in…

June 27, 2025 Off

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

By GlobeNewswire

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its…

June 27, 2025 Off

Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025

By GlobeNewswire

TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its…

June 27, 2025 Off

Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive Gel

By GlobeNewswire

Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut…

June 27, 2025 Off

Achieve Life Sciences Announces Proposed Underwritten Public Offering

By GlobeNewswire

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…

June 27, 2025 Off

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

By GlobeNewswire

Omnicom cross-agency collaboration to drive technology-led, innovative launch strategy Partnership brings together promising science, top-tier talent, and advanced technologies to…

June 27, 2025 Off

Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation

By GlobeNewswire

Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone…

Posts pagination

Previous 1 … 130 131 132 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine